N/A
Completed N=69
A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients
Cirrhosis, Liver · Hypertension · Ascites Hepatic
Source: ClinicalTrials.gov NCT05928624 ↗
Enrolled (actual)
69
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcomePrimary: Change in Mean Arterial Pressure — 0.5; 1 mmHg
Summary
This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Mean Arterial Pressure |
0.5; 1 | — |
| SECONDARY Change in Ascites Burden |
6.1; 4.7 | — |
Eligibility Criteria
Inclusion Criteria
- Patients will need to have decompensated cirrhosis defined as a Child Pugh Score ≥ 7
Exclusion Criteria
- None
Data sourced from ClinicalTrials.gov (NCT05928624). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.